MetLife Investment Management LLC Has $1.79 Million Stock Position in CorVel Co. (NASDAQ:CRVL)

MetLife Investment Management LLC increased its holdings in CorVel Co. (NASDAQ:CRVL - Free Report) by 213.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,050 shares of the business services provider's stock after purchasing an additional 10,923 shares during the period. MetLife Investment Management LLC's holdings in CorVel were worth $1,786,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Curi RMB Capital LLC grew its holdings in shares of CorVel by 200.0% in the 4th quarter. Curi RMB Capital LLC now owns 8,709 shares of the business services provider's stock worth $969,000 after purchasing an additional 5,806 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in CorVel by 187.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,545,619 shares of the business services provider's stock worth $171,969,000 after purchasing an additional 1,007,651 shares in the last quarter. First Trust Advisors LP grew its holdings in shares of CorVel by 338.6% during the fourth quarter. First Trust Advisors LP now owns 69,568 shares of the business services provider's stock worth $7,740,000 after purchasing an additional 53,707 shares during the last quarter. CANADA LIFE ASSURANCE Co increased its stake in shares of CorVel by 200.0% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 26,409 shares of the business services provider's stock valued at $2,938,000 after buying an additional 17,606 shares in the last quarter. Finally, Marshall Wace LLP bought a new position in shares of CorVel in the fourth quarter valued at about $671,000. Institutional investors own 51.36% of the company's stock.

CorVel Price Performance

Shares of CRVL stock traded down $1.24 during trading hours on Monday, reaching $110.79. The company had a trading volume of 12,693 shares, compared to its average volume of 119,020. CorVel Co. has a 1-year low of $76.53 and a 1-year high of $128.61. The firm has a market cap of $5.69 billion, a price-to-earnings ratio of 64.98 and a beta of 0.94. The company has a 50 day moving average of $110.38 and a 200 day moving average of $115.84.

CorVel (NASDAQ:CRVL - Get Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

Analyst Ratings Changes

Separately, StockNews.com raised shares of CorVel from a "hold" rating to a "buy" rating in a research note on Friday, April 18th.

Insider Activity at CorVel

In other news, Director Alan Hoops sold 10,200 shares of the business's stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total value of $1,187,178.00. Following the sale, the director now directly owns 118,213 shares in the company, valued at $13,758,811.07. The trade was a 7.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Brandon O'brien sold 1,523 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total transaction of $182,089.88. Following the transaction, the chief financial officer now owns 17,142 shares of the company's stock, valued at $2,049,497.52. The trade was a 8.16 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 48,723 shares of company stock worth $5,757,140. 47.57% of the stock is owned by company insiders.

CorVel Company Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.